Affinity DataKi: 0.800nMAssay Description:Affinity towards Dopamine receptor D2More data for this Ligand-Target Pair
Affinity DataKi: 2nMAssay Description:Affinity towards Dopamine receptor D2More data for this Ligand-Target Pair
Affinity DataKi: 3nMAssay Description:Affinity towards Dopamine receptor D1More data for this Ligand-Target Pair
Affinity DataKi: 20nMAssay Description:Affinity towards Dopamine receptor D2More data for this Ligand-Target Pair
Affinity DataKi: 20nMAssay Description:Affinity towards Dopamine receptor D1More data for this Ligand-Target Pair
Affinity DataKi: 30nMAssay Description:Affinity towards Dopamine receptor D1More data for this Ligand-Target Pair
Affinity DataKi: 40nMAssay Description:Affinity towards Dopamine receptor D1More data for this Ligand-Target Pair
Affinity DataKi: 50nMAssay Description:Affinity towards Dopamine receptor D2More data for this Ligand-Target Pair
Affinity DataKi: 50nMAssay Description:Affinity towards Dopamine receptor D2More data for this Ligand-Target Pair
Affinity DataKi: 77nMAssay Description:Affinity towards Dopamine receptor D1More data for this Ligand-Target Pair
Affinity DataKi: 320nMAssay Description:Affinity towards Dopamine receptor D1More data for this Ligand-Target Pair
Affinity DataKi: 340nMAssay Description:Affinity towards Dopamine receptor D2More data for this Ligand-Target Pair
Affinity DataKi: 350nMAssay Description:Affinity towards Dopamine receptor D2More data for this Ligand-Target Pair
Affinity DataKi: 510nMAssay Description:Affinity towards Dopamine receptor D2More data for this Ligand-Target Pair
Affinity DataKi: 810nMAssay Description:Affinity towards Dopamine receptor D2More data for this Ligand-Target Pair
Affinity DataKi: 1.20E+3nMAssay Description:Affinity towards Dopamine receptor D1More data for this Ligand-Target Pair
Affinity DataKi: 1.20E+3nMAssay Description:Affinity towards Dopamine receptor D1More data for this Ligand-Target Pair
Affinity DataKi: 1.35E+3nMAssay Description:Affinity towards Dopamine receptor D1More data for this Ligand-Target Pair
Affinity DataKi: 1.51E+3nMAssay Description:Affinity towards Dopamine receptor D1More data for this Ligand-Target Pair
Affinity DataKi: 1.70E+3nMAssay Description:Affinity towards Dopamine receptor D2More data for this Ligand-Target Pair
Affinity DataKi: 2.02E+3nMAssay Description:Affinity towards Dopamine receptor D1More data for this Ligand-Target Pair
Affinity DataKi: 2.57E+3nMAssay Description:Affinity towards Dopamine receptor D2More data for this Ligand-Target Pair
Affinity DataKi: 5.40E+3nMAssay Description:Affinity towards Dopamine receptor D1More data for this Ligand-Target Pair
Affinity DataKi: 7.94E+3nMAssay Description:Affinity towards Dopamine receptor D2More data for this Ligand-Target Pair
Affinity DataKi: 8.00E+3nMAssay Description:Affinity towards Dopamine receptor D2More data for this Ligand-Target Pair
Affinity DataKi: 9.55E+3nMAssay Description:Affinity towards Dopamine receptor D2More data for this Ligand-Target Pair
Affinity DataKi: 1.82E+4nMAssay Description:Affinity towards Dopamine receptor D1More data for this Ligand-Target Pair
Affinity DataKi: 2.00E+4nMAssay Description:Affinity towards Dopamine receptor D2More data for this Ligand-Target Pair
Affinity DataKi: 4.80E+4nMAssay Description:Affinity towards Dopamine receptor D1More data for this Ligand-Target Pair
Affinity DataKi: 1.60E+5nMAssay Description:Affinity towards Dopamine receptor D2More data for this Ligand-Target Pair
Affinity DataKi: 3.90E+5nMAssay Description:Affinity towards Dopamine receptor D1More data for this Ligand-Target Pair
Affinity DataKi: 5.25E+5nMAssay Description:Affinity towards Dopamine receptor D1More data for this Ligand-Target Pair
TargetCoagulation factor XI(Homo sapiens (Human))
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 0.400nMAssay Description:Inhibition of human F11a using D-Leu-Pro-Arg*Rh110-D-Pro as substrate preincubated for 60 mins followed by substrate addition and measured after 60 m...More data for this Ligand-Target Pair
TargetCoagulation factor XI(Homo sapiens (Human))
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Affinity DataIC50: <0.700nMAssay Description:Inhibition of human F11a using D-Leu-Pro-Arg*Rh110-D-Pro as substrate preincubated for 60 mins followed by substrate addition and measured after 60 m...More data for this Ligand-Target Pair
TargetCoagulation factor XI(Homo sapiens (Human))
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Affinity DataIC50: <0.700nMAssay Description:Inhibition of human F11a using D-Leu-Pro-Arg*Rh110-D-Pro as substrate preincubated for 60 mins followed by substrate addition and measured after 60 m...More data for this Ligand-Target Pair
TargetPlasma kallikrein(Homo sapiens (Human))
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibition of PKL (unknown origin) using D-Leu-Pro-Arg*Rh110-D-Pro as substrate preincubated for 60 mins followed by substrate addition and measured ...More data for this Ligand-Target Pair
TargetPlasma kallikrein(Homo sapiens (Human))
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibition of PKL (unknown origin) using D-Leu-Pro-Arg*Rh110-D-Pro as substrate preincubated for 60 mins followed by substrate addition and measured ...More data for this Ligand-Target Pair
TargetPlasma kallikrein(Homo sapiens (Human))
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Inhibition of PKL (unknown origin) using D-Leu-Pro-Arg*Rh110-D-Pro as substrate preincubated for 60 mins followed by substrate addition and measured ...More data for this Ligand-Target Pair
TargetPlasma kallikrein(Homo sapiens (Human))
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Inhibition of PKL (unknown origin) using D-Leu-Pro-Arg*Rh110-D-Pro as substrate preincubated for 60 mins followed by substrate addition and measured ...More data for this Ligand-Target Pair
TargetCoagulation factor XI(Homo sapiens (Human))
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Inhibition of human F11a using D-Leu-Pro-Arg*Rh110-D-Pro as substrate preincubated for 60 mins followed by substrate addition and measured after 60 m...More data for this Ligand-Target Pair
TargetCoagulation factor XI(Homo sapiens (Human))
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibition of human F11a using D-Leu-Pro-Arg*Rh110-D-Pro as substrate preincubated for 60 mins followed by substrate addition and measured after 60 m...More data for this Ligand-Target Pair
TargetCoagulation factor XI(Homo sapiens (Human))
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibition of human F11a using D-Leu-Pro-Arg*Rh110-D-Pro as substrate preincubated for 60 mins followed by substrate addition and measured after 60 m...More data for this Ligand-Target Pair
TargetCoagulation factor XI(Homo sapiens (Human))
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibition of human F11a using D-Leu-Pro-Arg*Rh110-D-Pro as substrate preincubated for 60 mins followed by substrate addition and measured after 60 m...More data for this Ligand-Target Pair
TargetPlasma kallikrein(Homo sapiens (Human))
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibition of PKL (unknown origin) using D-Leu-Pro-Arg*Rh110-D-Pro as substrate preincubated for 60 mins followed by substrate addition and measured ...More data for this Ligand-Target Pair
TargetCoagulation factor XI(Homo sapiens (Human))
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibition of human F11a using D-Leu-Pro-Arg*Rh110-D-Pro as substrate preincubated for 60 mins followed by substrate addition and measured after 60 m...More data for this Ligand-Target Pair
TargetCoagulation factor XI(Homo sapiens (Human))
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibition of human F11a using D-Leu-Pro-Arg*Rh110-D-Pro as substrate preincubated for 60 mins followed by substrate addition and measured after 60 m...More data for this Ligand-Target Pair
TargetPlasma kallikrein(Homo sapiens (Human))
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibition of PKL (unknown origin) using D-Leu-Pro-Arg*Rh110-D-Pro as substrate preincubated for 60 mins followed by substrate addition and measured ...More data for this Ligand-Target Pair
Affinity DataIC50: 5.30nMAssay Description:Inhibition of [3H]rolipram binding to Wistar rat brain membranesMore data for this Ligand-Target Pair
Affinity DataIC50: 6nMpH: 7.5 T: 2°CAssay Description:Briefly, recombinant human or murine FD catalytic domain (10 nM concentration) were incubated with compound at various concentrations for 1 h at room...More data for this Ligand-Target Pair
TargetCoagulation factor XI(Homo sapiens (Human))
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Novartis Institutes For Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 6nMAssay Description:Inhibition of human F11a using D-Leu-Pro-Arg*Rh110-D-Pro as substrate preincubated for 60 mins followed by substrate addition and measured after 60 m...More data for this Ligand-Target Pair